Exothera is a contract research, development, and manufacturing organization (CRDMO) dedicated to viral vector and nucleic acids production.
Belgium
Joined September 2020
- Tweets45
- Following85
- Followers90
- Likes27
Exothera retweeted
Member news! Meissa Vaccines enters into cGMP manufacturing agreement with @ExotheraWorld for pediatric RSV vaccine candidate for phase 2 clinical trials. tinyurl.com/4an4xzm7
Exothera Viral Vectors will manufacture Meissa Vaccines’s MV-012-968 vaccine candidate, an intranasal live attenuated RSV aiming to protect infants and young children from respiratory syncytial virus (RSV). Read the Press Release: shorturl.at/cT356
As Chief Technology Officer, Patrick Thiaville will help to accelerate the delivery of high-quality development and manufacturing services for the next generation of RNA therapies! 👏👍 Read the Press Release: exothera.world/exothera-nucl…
Exothera retweeted
@ExotheraWorld announces a strategic partnership with Quantoom Biosciences and launches a new business unit for the development and production of RNA #RNAproduction #CDMO
tinyurl.com/5n8twme8
[PRESS RELEASE] Exothera Nucleic Acids will be the world’s first CDMO with access to Quantoom Biosciences’s revolutionary Nfinity™ platform for the continuous production of RNA which Exothera will offer as a service! Discover the press release: bit.ly/3Abb2de
Exothera retweeted
Remedium and @ExotheraWorld partner on scale-up and demonstration runs for AAV2-FGF18 hubs.li/Q01HD2lN0 #Biotechnology #Osteoarthritis #GeneTherapy #CDMO
[PRESS RELEASE]
We are thrilled to announce this new collaboration in which Exothera will demonstrate the industrialization potential of @RemediumB's AAV-based gene therapy for the treatment of Osteoarthritis! Click here to discover the press release: bit.ly/40sAzcY
Exothera retweeted
@ExotheraWorld announces the appointment of Darren Leva as Chief Business Officer hubs.li/Q01zLbTn0 #CDMO #CBO #Biotherapeutics
We are thrilled to welcome Darren Leva as our new Chief Business Officer. With his extensive experience in the biotech industry and a proven track record of driving growth, he is the perfect addition to our team. 😀👍 READ THE PRESS RELEASE: bit.ly/3XVtXmL
Exothera retweeted
We’re delighted to announce @ExotheraWorld will be developing a large-scale manufacturing process for the clinical development of VALO-D102, our proprietary oncolytic adenovirus which forms part of our PeptiCRAd (Peptide-coated Conditionally Replicating Adenovirus) platform.
[PRESS RELEASE]
This collaboration among @EXOTHERA, LogicBio Therapeutics, and @Polyplus_Transf aims to develop a highly scalable and cost-effective AAV manufacturing platform! Read the press release: bit.ly/3zEeMFe
#GeneTherapy #vaccines #AAVManufacturing
[PRESS RELEASE]
This fully integrated platform will ensure faster, more cost-effective production of viral vector-based therapeutics (for gene therapy, vaccines, and oncolytic viruses for cancer treatment) at scale!
► READ THE PRESS RELEASE: bit.ly/3NAae6T
Exothera retweeted
This morning @ #CGMED22, we have company presentations from Anocca, Luminary Tx, @pdc_line, @FraunhoferIZI, @avectas, @ExotheraWorld, @SangamoTx, Autolus Tx, @AstellasUS, @GenSightBio, EG 427, @MARKEN_LLP, Quell Tx, & @Enzyvant. We're excited to hear from these industry leaders!
[PRESS RELEASE] This collaboration will be financed by a €3 million grant awarded by the Bill & Melinda Gates Foundation to develop and deliver new low-cost vaccines based on ReiThera’s GRAd technology platform. Read the Press Release: bit.ly/3riG2nQ
Exothera retweeted
‼️@ExotheraWorld Earns GMP Certification for #Jumet Facility‼️
Accreditation further extends CDMO's #viralvector manufacturing capacity
➡️ow.ly/1FZv50Ir9SC
#pharma #pharmanews #lifesciences #pharmamanufacturing
Exothera retweeted
🗣️ @montsedabanm, Scientific and International Relations Director at #Biocat, has participated today as a panelist at the session "Perspectives on the pan-European manufacturing landscape" together with Jerôme Fabiano from @EIThealth_FR & Thibault Jonckheere from @ExotheraWorld.
Exothera retweeted
Plongeon dans l’univers des #biotechs au travers de 3 filiales d’@UniverCell's, entreprise mondiale des sciences de la vie implantée en #Wallonie et dont l’objectif est d’élargir l’accès aux médicaments biologiques & les rendre plus abordables 💊
#Quantoom @ExotheraWorld
[PRESS RELEASE]
Rokote Laboratories and Exothera will collaborate to bring the intranasal coronavirus vaccine FINCoVac 2.0 to clinical Phase I/II trials! Read the press release: bit.ly/3JXgx2C
#GMPManufacturing #ViralVaccines #GeneTherapy
